CD4 and neoplasm: IDO expression has been observed in primary tumors and human tumor-draining lymph nodes in proximity to CD4+CD25+ regulatory T cells (Tregs), and studies with mice have revealed an IDO-dependent differentiation of naïve CD4+ T cells into Foxp3+ Tregs [9].